Overview
Richard Baker is a primary care provider, practicing in Internal Medicine in York, Pennsylvania. Dr. Baker is rated as an Experienced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Chronic B-Cell Leukemia (CBCL).
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
25 Monument Rd, Suite 140, York, PA 17403
Additional Areas of Focus
Dr. Baker has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Harry Kaplan is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Anemia, Vitamin B12 Deficiency, Subacute Combined Degeneration, and Pacemaker Implantation. Dr. Kaplan is currently accepting new patients.
Maryland Primary Care Physicians, LLC
Neil Padgett is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Padgett is rated as an Advanced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Common Cold, Type 2 Diabetes (T2D), Richter Syndrome, and Chronic B-Cell Leukemia (CBCL). Dr. Padgett is currently accepting new patients.
Jacob Cherian is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Cherian is rated as an Advanced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Sitosterolemia, Hypertension, Pica, Thrombectomy, and Laminectomy. Dr. Cherian is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic B-Cell Leukemia (CBCL)Dr. Baker isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Baker isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Familial HypertensionDr. Baker isExperienced. Learn about Familial Hypertension.
- Glucocorticoid-Remediable Aldosteronism
- HypertensionDr. Baker isExperienced. Learn about Hypertension.
- Maturity Onset Diabetes of the YoungDr. Baker isExperienced. Learn about Maturity Onset Diabetes of the Young.